# EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries

> **NCT01078402** · — · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 809 (actual)

## Conditions studied

- Ankylosing Spondylitis (AS)
- Psoriatic Arthritis (PsA
- Rheumatoid Arthritis (RA

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01078402
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 809 (ACTUAL)
- **Last updated:** 2013-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01078402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01078402, "EValuation of HumIRA® in Patients With Active Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis in EASTern European Countries". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01078402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*